Related Experiment Video
Updated: Mar 3, 2026

Neisseria meningitidis Infection of Induced Pluripotent Stem-Cell Derived Brain Endothelial Cells
Published on: July 14, 2020
IQGAP1 Mediates Hcp1-Promoted Escherichia coli Meningitis by Stimulating the MAPK Pathway
Mingna Zhao1, Lingfei Zhang2,3, Shaogang Lv1
1Department of Laboratory Medicine, Shanghai Chest Hospital, Shanghai Jiao Tong UniversityShanghai, China.
Abstract:
Escherichia coli-induced meningitis remains a life-threatening disease despite recent advances in the field of antibiotics-based therapeutics, necessitating continued research on its pathogenesis. The current study aims to elucidate the mechanism through which hemolysin-coregulated protein 1 (Hcp1) induces the apoptosis of human brain microvascular endothelial cells (HBMEC). Co-immunoprecipitation coupled with mass spectrometric (MS) characterization led to the identification of IQ motif containing GTPase activating protein 1 (IQGAP1) as a downstream target of Hcp1. IQGAP1 was found to be up-regulated by Hcp1 treatment and mediate the stimulation of HBMEC apoptosis. It was shown that Hcp1 could compete against Smurf1 for binding to IQGAP1, thereby rescuing the latter from ubiquitin-dependent degradation. Subsequent study suggested that IQGAP1 could stimulate the MAPK signaling pathway by promoting the phosphorylation of ERK1/2, an effect that was blocked by U0126, an MAPK inhibitor. Furthermore, U0126 also demonstrated therapeutic potential against E. coli meningitis in a mouse model. Taken together, our results suggested the feasibility of targeting the MAPK pathway as a putative therapeutic strategy against bacterial meningitis.
Insights
Hemolysin-coregulated protein 1 (Hcp1) from E. coli triggers brain cell death by upregulating IQGAP1, which activates the MAPK pathway. Inhibiting this pathway shows therapeutic potential for bacterial meningitis.
Area of Science:
- Neuroscience
- Microbiology
- Cell Biology
Background:
- Bacterial meningitis, particularly E. coli-induced, is a severe condition requiring new therapeutic strategies.
- Understanding the molecular mechanisms of bacterial pathogenesis is crucial for developing effective treatments.
Purpose of the Study:
- To investigate how hemolysin-coregulated protein 1 (Hcp1) induces apoptosis in human brain microvascular endothelial cells (HBMECs).
- To identify downstream targets of Hcp1 and explore their role in meningitis pathogenesis.
Main Methods:
- Co-immunoprecipitation and mass spectrometry were used to identify Hcp1-interacting proteins.
- Western blotting and apoptosis assays were performed to analyze protein expression and cell death.
- In vivo studies utilized a mouse model of E. coli meningitis.
Main Results:
- IQ motif containing GTPase activating protein 1 (IQGAP1) was identified as a downstream target of Hcp1.
- Hcp1 up-regulates IQGAP1, promoting HBMEC apoptosis by activating the MAPK/ERK1/2 signaling pathway.
- The MAPK inhibitor U0126 demonstrated therapeutic efficacy in a mouse model of E. coli meningitis.
Conclusions:
- Hcp1-induced HBMEC apoptosis is mediated by IQGAP1 and the MAPK signaling pathway.
- Targeting the MAPK pathway represents a promising therapeutic strategy for bacterial meningitis.
More Related Videos
Related Concept Videos
cAMP-dependent Protein Kinase Pathways
IP3/DAG Signaling Pathway
MAPK Signaling Cascades
GPCRs Regulate Adenylyl Cylase Activity
Microtubule Associated Proteins (MAPs)
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...

